FR3122991B1 - CRASSULACEAN ACID METABOLISM PLANT EXTRACT FOR USE IN THE TREATMENT OF DYSMENORRHEA AND/OR PAIN RELATED TO MENSTRUAL SPASMS AND CRAMPS - Google Patents
CRASSULACEAN ACID METABOLISM PLANT EXTRACT FOR USE IN THE TREATMENT OF DYSMENORRHEA AND/OR PAIN RELATED TO MENSTRUAL SPASMS AND CRAMPS Download PDFInfo
- Publication number
- FR3122991B1 FR3122991B1 FR2105309A FR2105309A FR3122991B1 FR 3122991 B1 FR3122991 B1 FR 3122991B1 FR 2105309 A FR2105309 A FR 2105309A FR 2105309 A FR2105309 A FR 2105309A FR 3122991 B1 FR3122991 B1 FR 3122991B1
- Authority
- FR
- France
- Prior art keywords
- dysmenorrhea
- treatment
- acid metabolism
- cramps
- spasms
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 208000007101 Muscle Cramp Diseases 0.000 title abstract 4
- 208000005171 Dysmenorrhea Diseases 0.000 title abstract 3
- 206010013935 Dysmenorrhoea Diseases 0.000 title abstract 3
- 239000002253 acid Substances 0.000 title abstract 3
- 230000004060 metabolic process Effects 0.000 title abstract 3
- 208000002193 Pain Diseases 0.000 title abstract 2
- 208000005392 Spasm Diseases 0.000 title abstract 2
- 230000002175 menstrual effect Effects 0.000 title abstract 2
- 239000000419 plant extract Substances 0.000 title abstract 2
- 239000000284 extract Substances 0.000 abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/33—Cactaceae (Cactus family), e.g. pricklypear or Cereus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Botany (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Reproductive Health (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
EXTRAIT DE VEGETAL A METABOLISME ACIDE CRASSULACEEN pour utilisation dans le traitement de la dysménorrhée et/ou des douleurs liées aux spasmes et crampes menstruels La présente invention concerne un extrait d’au moins un végétal à métabolisme acide crassulacéen pour utilisation dans le traitement de la dysménorrhée. La présente invention concerne également une composition pharmaceutique comprenant un extrait selon l’invention.PLANT EXTRACT WITH CRASSULACEAN ACID METABOLISM for use in the treatment of dysmenorrhea and/or pain linked to menstrual spasms and cramps. The present invention relates to an extract of at least one plant with crassulacean acid metabolism for use in the treatment of dysmenorrhea . The present invention also relates to a pharmaceutical composition comprising an extract according to the invention.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR2105309A FR3122991B1 (en) | 2021-05-20 | 2021-05-20 | CRASSULACEAN ACID METABOLISM PLANT EXTRACT FOR USE IN THE TREATMENT OF DYSMENORRHEA AND/OR PAIN RELATED TO MENSTRUAL SPASMS AND CRAMPS |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR2105309A FR3122991B1 (en) | 2021-05-20 | 2021-05-20 | CRASSULACEAN ACID METABOLISM PLANT EXTRACT FOR USE IN THE TREATMENT OF DYSMENORRHEA AND/OR PAIN RELATED TO MENSTRUAL SPASMS AND CRAMPS |
| FR2105309 | 2021-05-20 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR3122991A1 FR3122991A1 (en) | 2022-11-25 |
| FR3122991B1 true FR3122991B1 (en) | 2024-05-31 |
Family
ID=78332825
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR2105309A Active FR3122991B1 (en) | 2021-05-20 | 2021-05-20 | CRASSULACEAN ACID METABOLISM PLANT EXTRACT FOR USE IN THE TREATMENT OF DYSMENORRHEA AND/OR PAIN RELATED TO MENSTRUAL SPASMS AND CRAMPS |
Country Status (1)
| Country | Link |
|---|---|
| FR (1) | FR3122991B1 (en) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2757863B1 (en) | 1996-12-27 | 1999-03-26 | Inovat Sarl | NOVEL BIOLOGICALLY ACTIVE SUBSTANCES, PROCESS FOR OBTAINING SAME AND COMPOSITIONS CONTAINING SAME |
| WO2002005830A2 (en) * | 2000-07-14 | 2002-01-24 | Shantaram Govind Kane | Extracts from crassulacean acid metabolism (cam) mechanism plants and uses thereof |
| EP1932531A1 (en) | 2006-12-11 | 2008-06-18 | Finzelberg GmbH & Co. KG | Special extract and its use to inhibit the decomposition of cyclical guanosinmonophosphate (cGMP) |
| KR101808944B1 (en) * | 2016-04-27 | 2017-12-13 | 충북대학교 산학협력단 | Composition for preventing and treating dysmenorrhea and premature labor comprising non-polar solvent subfraction from Zingiber officinale extract |
| WO2018134848A1 (en) | 2017-01-20 | 2018-07-26 | Laila Nutraceuticals | Dietary supplements for inhibiting pde5 and increasing cgmp levels |
-
2021
- 2021-05-20 FR FR2105309A patent/FR3122991B1/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| FR3122991A1 (en) | 2022-11-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA52492B1 (en) | RIP1 INHIBITORY COMPOUNDS, METHODS OF PREPARATION AND USE THEREOF | |
| MA41072A1 (en) | New pyoverine and pyochelin specific proteins | |
| MA30047B1 (en) | PROCESS FOR TREATING JOINT LESION | |
| MA34726B1 (en) | PREVENTING SIDE EFFECTS CAUSED BY SPECIFIC CD3 LINKAGE DOMAINS | |
| TNSN98211A1 (en) | COMBINATION OF AN ALDOSE-REDUCTASE INHIBITOR AND A GLYCOGENE-PHOSPHORYLASE INHIBITOR, AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME | |
| MA46611B1 (en) | Combination therapies including imidazopyrazinones for the treatment of psychiatric and / or cognitive disorders | |
| TNSN99133A1 (en) | IMPROVED PROCESS FOR THE PREPARATION OF SCHIFF BASES AND PRODUCTS THUS OBTAINED | |
| MA54975B1 (en) | ANTI-PCRV ANTIBODIES THAT BIND TO PCRV, COMPOSITIONS COMPRISING ANTI-PCRV ANTIBODIES, AND METHODS OF USE THEREOF | |
| Ekuni et al. | Vitamin C intake attenuates the degree of experimental atherosclerosis induced by periodontitis in the rat by decreasing oxidative stress | |
| López-Domínguez et al. | Dietary fat modifies mitochondrial and plasma membrane apoptotic signaling in skeletal muscle of calorie-restricted mice | |
| MA20150436A1 (en) | Pharmaceutical preparation | |
| FR3122991B1 (en) | CRASSULACEAN ACID METABOLISM PLANT EXTRACT FOR USE IN THE TREATMENT OF DYSMENORRHEA AND/OR PAIN RELATED TO MENSTRUAL SPASMS AND CRAMPS | |
| TNSN07430A1 (en) | SYNERGISTIC ASSOCIATIONS OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS WITH ALPHA-2-DELTA LIGANDS | |
| Moretti et al. | Small vessel disease: ancient description, novel biomarkers | |
| PT769915E (en) | USING A FRACTION CONTAINING ORGANIC ACIDS AND A FRACTION CONTAINING ACIDS | |
| MA31130B1 (en) | COMBINATION COMPRISING IRON CHELATANT AND ANTINEOPLASTIC AGENT AND APPLICATIONS THEREOF | |
| FR2907338B1 (en) | USE OF FERULIC ACID IN THE COSMETIC AND / OR PHARMACEUTICAL FIELD | |
| MA38699A1 (en) | Oral formulation for the treatment of cardiovascular diseases | |
| FR3122990B1 (en) | Plant extract with crassulacean acid metabolism for use in the treatment of erectile dysfunction | |
| MA27690A1 (en) | ANDROGENIC PHARMACEUTICAL COMPOSITION AND METHOD FOR THE TREATMENT OF DEPRESSION. | |
| FR3059236B1 (en) | EXTRACTS FROM PLANTS OF THE GENUS TAGETES AND USES THEREOF | |
| FR3100128B1 (en) | Pharmaceutical composition for inhibiting HIV infectivity, treating acquired immunodeficiency syndrome (AIDS) and its complications | |
| Toda et al. | Effect of aluminum on iron-induced lipid peroxidation and protein oxidative modification of mouse brain homogenate | |
| Gazulla et al. | Two-year follow-up of docosahexaenoic acid supplementation in spinocerebellar ataxia type 38 (SCA38) | |
| MA53521A1 (en) | New mpro protease and sars-cov2 replication inhibitor compounds, their formulations and applications |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PLFP | Fee payment |
Year of fee payment: 2 |
|
| PLSC | Publication of the preliminary search report |
Effective date: 20221125 |
|
| PLFP | Fee payment |
Year of fee payment: 3 |
|
| PLFP | Fee payment |
Year of fee payment: 4 |